Analysen von Peter Welford
| 04.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 16.05.24 | Roche Hold | Jefferies & Company Inc. | |
| 13.05.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.05.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.04.24 | QIAGEN Hold | Jefferies & Company Inc. | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 25.04.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 25.04.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 26.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.02.24 | QIAGEN Hold | Jefferies & Company Inc. | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.24 | Roche Hold | Jefferies & Company Inc. | |
| 31.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 26.01.24 | EVOTEC Buy | Jefferies & Company Inc. | |
| 16.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.01.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 16.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 16.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 03.01.24 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 03.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 03.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 08.12.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 04.12.23 | Roche Hold | Jefferies & Company Inc. | |
| 28.11.23 | Novartis Buy | Jefferies & Company Inc. | |
| 27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 27.11.23 | EVOTEC Buy | Jefferies & Company Inc. | |
| 27.11.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 22.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 16.11.23 | GSK Hold | Jefferies & Company Inc. | |
| 15.11.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 13.11.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.11.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.11.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.11.23 | GSK Hold | Jefferies & Company Inc. | |